2. As of noon trading, Verisk Analytics ( VRSK) is down $0.48 (-1.0%) to $49.36 on average volume Thus far, 264,078 shares of Verisk Analytics exchanged hands as compared to its average daily volume of 694,100 shares. The stock has ranged in price between $49.09-$49.93 after having opened the day at $49.79 as compared to the previous trading day's close of $49.84.

Verisk Analytics, Inc. provides proprietary data, analytics methods, and embedded decision support solutions for detecting fraud in property and casualty (P&C) insurance, mortgage, and healthcare industries primarily in the United States. Verisk Analytics has a market cap of $8.3 billion and is part of the services sector. The company has a P/E ratio of 25.8, above the S&P 500 P/E ratio of 17.7. Shares are up 23.4% year to date as of the close of trading on Friday. Currently there are 7 analysts that rate Verisk Analytics a buy, no analysts rate it a sell, and 5 rate it a hold.

TheStreet Ratings rates Verisk Analytics as a buy. The company's strengths can be seen in multiple areas, such as its notable return on equity, robust revenue growth, expanding profit margins, solid stock price performance and impressive record of earnings per share growth. We feel these strengths outweigh the fact that the company has had generally high debt management risk by most measures that we evaluated. Get the full Verisk Analytics Ratings Report now.

EXCLUSIVE OFFER: Jim Cramer's Protégé, Dave Peltier, only buys Stocks Under $10 that he thinks could potentially double. See what he's trading today with a 14-day FREE pass

If you liked this article you might like

Biotech Movers: Jazz Shares Lower Amid Notes Offering

Biotech Movers: Myriad Genetics, Spectrum Pharmaceuticals, Array BioPharma

Bullish and Bearish Reversals in the Market

Biotech Premarket Movers: Sage Therapeutics, Immunomedics, Myriad Genetics

Gilead Sciences Leads Biotech Movers -- Plus Jim Cramer's Comments